Highlights of recent US patent applications on protein biomarkers and molecular diagnostics.
1. Biomarkers associated with early death in the general population
2. New predictive biomarker of response to cetuximab in metastatic colorectal cancer patients
3. Predictive biomarker of response to combination therapy in metastatic colorectal cancer patients
4. SNP markers for the determination the risk of developing schizophrenia
5. Serum biomarkers for the diagnosis and prognosis of dengue fever (DF)
6. Protein biomarkers for the diagnosis and predicting premature birth (PTB)
7. Endocan as a serum biomarker of sepsis
8. Gene expression markers for diagnosis and prognosis of lung cancer
9. A novel microRNA for the diagnosis of cardiovascular disorders
10. Biomarker panel for the diagnosis and monitoring the progression and treatment of stroke
11. Biomarker panel for the diagnosis of schizophrenia or other psychotic disorders
12. Multiplex bead array based assays for the diagnosis of autoimmune diseases
13. Biomarkers for predicting mortality and detecting the presence of severe disease
14. BRCA Ashkenazi mutation specific antibody test for breast cancer
16. BRCA tissue truncation test for the diagnosis of breast cancer
17. Urinary biomarkers for the diagnosis of preeclampsia
18. Biomarker panel for the diagnosis and prediction of graft rejection
Details: http://www.sciclips.com/sciclips/biomarker-news.do
